Vertex Pharmaceuticals · 7 hours ago
Senior Manager, US Market Access Data Enablement
Boston, MA
Full-time
Hybrid
Senior Level
$164K/yr - $246K/yr
6+ years expVertex Pharmaceuticals is seeking a Senior Manager, US Market Access Data Enablement to join the U.S. Market Access organization. This role will focus on ensuring essential data assets are governed, catalogued, acquired, and made analytics ready to support Vertex USMA's analytics and intelligence needs across pipeline, launch and in-line assets.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead efforts to understand and map business data needs related to Access Strategy, Pricing & Contracting, Trade & Distribution Operations, and Payer Field Teams to data sources and data products
Assess and document data requirements for new product launches, pipeline programs, and in-line brands, ensuring timely availability and usability of high-quality data
Partner with internal and external teams to validate, and onboard third-party and internal data sources, including Model N, Integrichain 852/867, MMIT, IQVIA claims (LAAD), sales data (DDD, Xponent) and acquire any additional third party data to fit business needs
Own the implementation and continuous improvement of data governance processes, ensuring compliance with regulatory, legal, and ethical guidelines, including data privacy and access control in accordance with industry standards (e.g., HIPAA, 21 CFR Part 11)
Maintain a data catalog and associated metadata for market access data domains to promote discoverability, lineage tracking, and business understanding
Establish and monitor data quality KPIs (e.g., completeness, accuracy, timeliness) and lead issue resolution workflows across critical datasets
Collaborate with Digital Technology and Engineering (DTE), Commercial Operations, and PACM teams to develop scalable processes for data access, harmonization, and integration
Provide subject matter expertise on data stewardship practices, enabling effective use of data by cross-functional market access stakeholders
Leverage data platforms including Snowflake to extract, transform, and load large datasets across payer accounts, pricing, distribution, and field operations
Partner cross-functionally (~30% of time) with Market Access Strategy, PACM, Commercial Analytics, and Trade teams to align analytics to key business decisions
Communicate Data Readiness and Maturity through executive-ready PowerPoint presentations and strategic storytelling tailored for Director and VP-level audiences
Serve as subject matter expert to support analytics using key data sets: Model N, Integrichain 852/867, MMIT, IQVIA LAAD, DDD, and Xponent
Support the evolution of D&A tools and capabilities that enable scalable insights, automation, and advanced analytics across Market Access functions
Qualification
Required
Bachelor's degree in a quantitative discipline (e.g., Statistics, Engineering, Data Science, Economics)
6+ years of experience in pharmaceuticals/biotech or consulting with direct focus on Market Access analytics
Hands-on experience with Model N, MMIT, Integrichain 852/867, IQVIA LAAD/DDD/Xponent
Proven Experience in data governance including policy development, access controls, regulatory compliance, and ethical data handling in life sciences
Experienced in data cataloging, metadata management, and data quality monitoring tools
Strong communication skills and experience presenting to cross-functional stakeholders
Preferred
Experience in launch planning and commercial readiness analytics
Familiarity with Medicaid, Medicare Part D, 340B, and commercial payer dynamics
Ability to work independently and manage multiple priorities in a fast-paced environment
Demonstrated ability to align technical solutions with strategic objectives
Benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (151)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Michael Partridge
Senior Vice President, Investor Relations
Recent News
The Motley Fool
2025-12-30
The Motley Fool
2025-12-28
The Motley Fool
2025-12-27
Company data provided by crunchbase